MedTrace Logo

Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals

NCT04321369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2022-05-04

No results posted yet for this study

Summary

Operational project to compare clinician collected nasopharyngeal (NP) samples to patient-obtained tongue, nasal and mid-turbinate (MT) samples in the detection of SARS-CoV-2 in an outpatient clinic setting

Conditions

Interventions

DIAGNOSTIC_TEST

Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals

This is an operational project. Patients will collect a sample from the tongue, nasal cavity and MT and then clinicians will collect a NP sample from the nostril corresponding to each participant's dominant hand.

Sponsors & Collaborators

  • Quest Diagnostics-Nichols Insitute

    collaborator INDUSTRY

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • UnitedHealth Group

    lead INDUSTRY

Principal Investigators

  • Ethan Berke, MD · UnitedHealth Group

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-09
Primary Completion
2020-03-23
Completion
2020-03-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04321369 on ClinicalTrials.gov